| Title : The selective butyrylcholinesterase inhibitor UW-MD-95 shows symptomatic and neuroprotective effects in a pharmacological mouse model of Alzheimer's disease - Carles_2024_CNS.Neurosci.Ther_30_e14814 |
| Author(s) : Carles A , Hoffmann M , Scheiner M , Crouzier L , Bertrand-Gaday C , Chatonnet A , Decker M , Maurice T |
| Ref : CNS Neurosci Ther , 30 :e14814 , 2024 |
| Abstract : |
| PubMedSearch : Carles_2024_CNS.Neurosci.Ther_30_e14814 |
| PubMedID: 38887858 |
| Title : Dual-Acting Small Molecules: Subtype-Selective Cannabinoid Receptor 2 Agonist\/Butyrylcholinesterase Inhibitor Hybrids Show Neuroprotection in an Alzheimer's Disease Mouse Model - Spatz_2023_J.Med.Chem__ |
| Author(s) : Spatz P , Steinmuller SAM , Tutov A , Poeta E , Morilleau A , Carles A , Deventer MH , Hofmann J , Stove CP , Monti B , Maurice T , Decker M |
| Ref : Journal of Medicinal Chemistry , : , 2023 |
| Abstract : |
| PubMedSearch : Spatz_2023_J.Med.Chem__ |
| PubMedID: 37127287 |
| Title : Fluoroethylnormemantine (FENM) shows synergistic protection in combination with a sigma-1 receptor agonist in a mouse model of Alzheimer's disease - Freyssin_2023_Neuropharmacol__109733 |
| Author(s) : Freyssin A , Carles A , Guehairia S , Rubinstenn G , Maurice T |
| Ref : Neuropharmacology , :109733 , 2023 |
| Abstract : |
| PubMedSearch : Freyssin_2023_Neuropharmacol__109733 |
| PubMedID: 37844867 |
| Title : Photoswitchable Pseudoirreversible Butyrylcholinesterase Inhibitors Allow Optical Control of Inhibition in Vitro and Enable Restoration of Cognition in an Alzheimer's Disease Mouse Model upon Irradiation - Scheiner_2022_J.Am.Chem.Soc__ |
| Author(s) : Scheiner M , Sink A , Hoffmann M , Vrigneau C , Endres E , Carles A , Sotriffer C , Maurice T , Decker M |
| Ref : Journal of the American Chemical Society , : , 2022 |
| Abstract : |
| PubMedSearch : Scheiner_2022_J.Am.Chem.Soc__ |
| PubMedID: 35138833 |